New Guinea Impatiens variety SAKIMP053
AssigneeSakata Seed Corporation
InventorChihiro Sato
Life of this patent
Estimating the term…
Loading patent…
AssigneeSakata Seed Corporation
InventorChihiro Sato
Estimating the term…
A New Guinea Impatiens plant designated SAKIMP053 is disclosed. Embodiments include seeds of New Guinea Impatiens SAKIMP053, plants of New Guinea Impatiens SAKIMP053, to plant parts of New Guinea Impatiens SAKIMP053, and methods for producing an impatiens plant produced by crossing New Guinea Impatiens SAKIMP053 with itself or with another impatiens variety. Embodiments include methods for producing an impatiens plant containing in its genetic material one or more genes or transgenes and transgenic impatiens plants and plant parts produced by those methods. Embodiments also relate to impatiens varieties, breeding varieties, plant parts, and cells derived from New Guinea Impatiens SAKIMP053, methods for producing other impatiens lines or plant parts derived from New Guinea Impatiens SAKIMP053, and the impatiens plants, varieties, and their parts derived from use of those methods. Embodiments further include hybrid impatiens seeds, plants, and plant parts produced by crossing New Guinea Impatiens SAKIMP053 with another impatiens variety.
A plant of New Guinea Impatiens variety SAKIMP053, wherein a representative sample of plant tissue of said variety was deposited under NCMA No. 201907010.
A method of editing the genome of New Guinea Impatiens plant, or a plant part of, SAKIMP053, wherein a representative sample of plant tissue was deposited under NCMA No 201907010, and wherein said method is selected from the group comprising zinc finger nucleases, transcription activator-like effector nucleases (TALENs), engineered homing endonucleases/meganucleases, and the clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein9 (Cas9) system.
Dependencies are inferred from the claim text.